AngioDynamics, Inc.ANGONASDAQ
Loading
| Metric | May 21 | May 22 | May 23 |
|---|---|---|---|
| Revenue | 291 | 316 | 339 |
| Gross Profit | 157 | 166 | 174 |
| Operating Income | -35 | -28 | -51 |
| Net Income | -32 | -27 | -52 |
| EBITDA | -9 | 11 | 12 |
| EPS Diluted | -0.82 | -0.68 | -1.33 |
| Metric | May 21 | May 22 | May 23 |
|---|---|---|---|
| Cash & Equivalents | 48 | 29 | 45 |
| Total Current Assets | 141 | 143 | 164 |
| Total Assets | 561 | 553 | 533 |
| Total Current Liabilities | 58 | 74 | 84 |
| Total Liabilities | 122 | 128 | 154 |
| Total Equity | 439 | 424 | 378 |
| Total Debt | 20 | 34 | 65 |
| Net Debt | -28 | 5 | 20 |
| Metric | May 21 | May 22 | May 23 |
|---|---|---|---|
| Operating Cash Flow | 24 | -7 | 0 |
| Capital Expenditure | -5 | -4 | -4 |
| Free Cash Flow | 19 | -11 | -4 |
| Stock-Based Comp | 9 | 11 | 11 |
| Net Change in Cash | -6 | -19 | 16 |